drug protocol number

RC 12-079

drug sponsor

Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG)

drug study

Dexmedetomidine

drug trial site

King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah)

drug status

Ongoing

drug phase